Toggle navigation

Menu
Home
Medicines ${arrow_down}$
Companies
Latest updates
About emc
Help
Log in Sign up

Search emc: Enter medicine name or company

Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.

Advanced search

${list_note}$

My Account Area

${note_holder_search}$ Find similar products:

Same active ingredient
Same company
By ATC code

${info_black}$

View changes

Notifications

${border_star}$ Add to Favourites

Share via email

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.

Go to ${yellow_card_logo}$ site

${arrow_up}$ Back to top

Syonell 500mg Gastro-Resistant Tablets ${equilateral_black_triangle}$

Active Ingredient:

valproate semisodium

Company:

Lupin Healthcare (UK) Ltd See contact details

ATC code:

N05AX

${info_black}$

About Medicine

${medical_services}$

Prescription only medicine

My Account Area

${arrow_down}$

${note_holder_search}$ Find similar products:

Same active ingredient
Same company
By ATC code

${info_black}$

View changes

Notifications

${border_star}$ Add to Favourites

Share via email

Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs

${arrow_left}$

${arrow_right}$

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

${pdf_link}$

Advice for male patients_MHRA

${healthcare_pro_orange}$ For Healthcare Professionals

This is for healthcare professionals to provide to male patients taking valproate as well as their families and caregivers.

${pdf_link}$

Annual Risk Acknowledgement Form for Female Patients

THIS INTERACTIVE FORM IS NOT INTENDED FOR HARD COPY USE. Interactive form for use with girls and women of childbearing potential taking this product. It is to be completed with their specialist at least once a year to make sure they know and have understood all the risks related to the use of valproate during pregnancy and the need to avoid becoming pregnant while taking valproate.

${external_link}$

MHRA Advice for HCP's Valproate review, not for male already taking valproate

${healthcare_pro_orange}$ For Healthcare Professionals

Valproate (Blevo, Convulex, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): review by two specialists is required for initiating valproate but not for male patients already taking valproate.

${pdf_link}$

MHRA Valproate Risk minimisation measures, 55 or older

${healthcare_pro_orange}$ For Healthcare Professionals

Risk minimisation measures required for Valproate prescribing - This is for the patient 55 years old or over

${pdf_link}$

MHRA Valproate Risk minimisation measures, Female under 55

${healthcare_pro_orange}$ For Healthcare Professionals

Risk minimisation measures required for Valproate prescribing - This is for the female patients less than 55 years old.

${pdf_link}$

MHRA Valproate Risk minimisation measures, Male under 55

${healthcare_pro_orange}$ For Healthcare Professionals

Risk minimisation measures required for Valproate prescribing - This is for the male patients less than 55 years old.

${pdf_link}$

Valproate - Patient Guide

Educational material for patients on important safety information associated with Valproate use.

${pdf_link}$

Valproate Male Risk Acknowledgement Form

THIS INTERACTIVE FORM IS NOT INTENDED FOR HARD COPY USE. Interactive form for male patients aged under 55 years to complete with their specialists when starting valproate.

${pdf_link}$